Literature DB >> 8061873

An in-vitro investigation of prosthetic heart valve cavitation in blood.

L A Garrison1, T C Lamson, S Deutsch, D B Geselowitz, R P Gaumond, J M Tarbell.   

Abstract

Vapor cavities produced by low pressure fluid flow conditions have been observed in the vicinity of mechanical heart valves for many years. As cavities collapse during pressure recovery, they can produce stresses large enough to cause pitting of the valve occluders and lysing or activation of blood cells. To date, no method has been presented for the quantification of mechanical heart valve cavitation in blood because it has only been detected optically in transparent blood analog fluids. This paper describes a novel method for quantifying cavitation intensities in opaque fluids such as blood. It is based on the detection of high frequency pressure oscillations (35-350 kHz) at a location 4.5 cm proximal to a Björk-Shiley monostrut mitral valve in a mock circulatory loop driven by a Penn State Electric Ventricular Assist Device. The pressure oscillations which result from cavity collapse are used to quantify cavitation intensities in blood. One time domain and three frequency domain parameters have been developed to quantify cavitation intensity during a single valve closure event and over an ensemble of closure events. The time domain parameter is the Root Mean Squared (RMS) value of the pressure signal after it has been high-pass filtered at 35 kHz. The other three parameters are derived from the power spectrum of the pressure signal. One is the maximum value of the power spectrum between 100 and 200 kHz, another is the area under the power spectrum between 35 and 400 kHz, and the last is the volume under a 3-dimensional time vs. frequency vs. power spectrum plot. The parameters are averaged over a random sample of pressure traces to determine an average cavitation intensity for each operating condition studied. In addition, cavitation pressure fluctuations and hemolysis rates were determined simultaneously at several different mock flow loop operating conditions using porcine blood, and the relationships between various measures of cavitation intensity and the associated index of hemolysis have been established. Hemolysis was shown to increase with cavitation intensity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061873

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  7 in total

Review 1.  Cavitation in medicine.

Authors:  Christopher Earls Brennen
Journal:  Interface Focus       Date:  2015-10-06       Impact factor: 3.906

2.  Three-dimensional fluid-structure interaction simulation of bileaflet mechanical heart valve flow dynamics.

Authors:  Rui Cheng; Yong G Lai; Krishnan B Chandran
Journal:  Ann Biomed Eng       Date:  2004-11       Impact factor: 3.934

3.  Mechanism for cavitation of monoleaflet and bileaflet valves in an artificial heart.

Authors:  Hwansung Lee; Eisuke Tatsumi; Akihiko Homma; Tomonori Tsukiya; Yoshiyuki Taenaka
Journal:  J Artif Organs       Date:  2006       Impact factor: 1.731

4.  Observation of cavitation pits on a mechanical heart valve surface in an artificial heart used in in vivo testing.

Authors:  Hwansung Lee; Akihiko Homma; Eisuke Tatsumi; Yoshiyuki Taenaka
Journal:  J Artif Organs       Date:  2009-06-18       Impact factor: 1.731

5.  Wavelet analysis of valve closing sound detects malfunction of bileaflet mechanical valve.

Authors:  Hiroshi Sugiki; Toshifumi Murashita; Norihiko Shiiya; Yoshiro Matsui; Kenji Sugiki
Journal:  J Artif Organs       Date:  2008-04-15       Impact factor: 1.731

6.  Can vortices in the flow across mechanical heart valves contribute to cavitation?

Authors:  I Avrahami; M Rosenfeld; S Einav; M Eichler; H Reul
Journal:  Med Biol Eng Comput       Date:  2000-01       Impact factor: 3.079

7.  Signal processing of heart signals for the quantification of non-deterministic events.

Authors:  Véronique Millette; Natalie Baddour
Journal:  Biomed Eng Online       Date:  2011-01-26       Impact factor: 2.819

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.